Literature DB >> 9097380

Tularemia pneumonia.

V Gill1, B A Cunha.   

Abstract

Tularemia pneumonia may complicate the various clinical presentations of tularemia, or present as an uncommon zoonosis. Approximately 200 cases of tularemia are reported in the United States per year, and 10% to 20% present with pneumonia either as a primary event or as a complication of ulceroglandular or typhoidal tularemia. Tularemia pneumonia also occurs with the other tularemic forms, glandular, oculoglandular, and oropharyngeal tularemia as a result of secondary bacteremic spread to the lungs. Pneumonia usually occurs within 2 days to months after infection. The mortality rate of primary tularemic pneumonia and pneumonia complicating typhoidal tularemia is high. The clinical and roentgenographic presentations of tularemia pneumonia are highly variable and is one of the zoonotic atypical pneumonias. Tularemic pneumonia may mimic fungal and bacterial pneumonias, tuberculosis, or malignancy. The diagnosis of tularemic pneumonia should be considered in any patient presenting with an atypical pneumonia with the finding of an ulcer and/or lymphadenopathy and a history of outdoor activity. Serum agglutination tests and ELISA are the basis of serological diagnosis. Francisella tularensis can be cultured from the sputum, skin ulcer, pleural fluid, and the lymph nodes, but cultures should not be obtained because of the danger to laboratory personnel. The drug preferred for treatment of tularemic pneumonia is streptomycin for 1 to 2 weeks.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9097380

Source DB:  PubMed          Journal:  Semin Respir Infect        ISSN: 0882-0546


  22 in total

1.  Elevated AIM2-mediated pyroptosis triggered by hypercytotoxic Francisella mutant strains is attributed to increased intracellular bacteriolysis.

Authors:  Kaitian Peng; Petr Broz; Jonathan Jones; Lydia-Marie Joubert; Denise Monack
Journal:  Cell Microbiol       Date:  2011-08-24       Impact factor: 3.715

2.  Tularemia in the Southeastern Swiss Alps at 1,700 m above sea level.

Authors:  M Ernst; P Pilo; F Fleisch; P Glisenti
Journal:  Infection       Date:  2014-08-21       Impact factor: 3.553

3.  Indoleamine 2,3-dioxygenase 1 is a lung-specific innate immune defense mechanism that inhibits growth of Francisella tularensis tryptophan auxotrophs.

Authors:  Kaitian Peng; Denise M Monack
Journal:  Infect Immun       Date:  2010-04-12       Impact factor: 3.441

4.  Sensitive Detection of Francisella tularensis Directly from Whole Blood by Use of the GeneXpert System.

Authors:  Padmapriya P Banada; Srinidhi Deshpande; Soumitesh Chakravorty; Riccardo Russo; James Occi; Gabriel Meister; Kelly J Jones; Carl H Gelhaus; Michelle W Valderas; Martin Jones; Nancy Connell; David Alland
Journal:  J Clin Microbiol       Date:  2016-12-28       Impact factor: 5.948

5.  Construction and characterization of an attenuated purine auxotroph in a Francisella tularensis live vaccine strain.

Authors:  Roger Pechous; Jean Celli; Renee Penoske; Stanley F Hayes; Dara W Frank; Thomas C Zahrt
Journal:  Infect Immun       Date:  2006-08       Impact factor: 3.441

6.  Epitope-based vaccination against pneumonic tularemia.

Authors:  Stephen H Gregory; Stephanie Mott; Jennifer Phung; Jinhee Lee; Leonard Moise; Julie A McMurry; William Martin; Anne S De Groot
Journal:  Vaccine       Date:  2009-07-17       Impact factor: 3.641

7.  Identification of immunologic and pathologic parameters of death versus survival in respiratory tularemia.

Authors:  Damiana Chiavolini; Joseph Alroy; Carol A King; Peter Jorth; Susan Weir; Guillermo Madico; John R Murphy; Lee M Wetzler
Journal:  Infect Immun       Date:  2007-11-19       Impact factor: 3.441

8.  A case of primary tularemic pneumonia presenting with necrotizing mediastinal and hilar lymph nodes.

Authors:  Arschang Valipour; Hubert Koller; Alois Kreuzer; Wolfgang Kössler; Anna Csokay; Otto Chris Burghuber
Journal:  Wien Klin Wochenschr       Date:  2003-03-31       Impact factor: 1.704

9.  Discrimination of human pathogenic subspecies of Francisella tularensis by using restriction fragment length polymorphism.

Authors:  Rebecca Thomas; Anders Johansson; Brendan Neeson; Karen Isherwood; Anders Sjöstedt; Jill Ellis; Richard W Titball
Journal:  J Clin Microbiol       Date:  2003-01       Impact factor: 5.948

Review 10.  Tularemia.

Authors:  Jill Ellis; Petra C F Oyston; Michael Green; Richard W Titball
Journal:  Clin Microbiol Rev       Date:  2002-10       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.